Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Phathom Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 28.00 and a low estimate of 18.00. The median estimate represents a 199.79% increase from the last price of 9.34.
High | 199.8% | 28.00 |
Med | 199.8% | 28.00 |
Low | 92.7% | 18.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 05, 2025.
Average growth rate | -19.88% |
Average growth rate | +18.70% |
More ▼
Revenue history & estimates in USD
Average growth rate | +195.56% |
Average growth rate | 0.00% |
More ▼